Browse Studies — Arctuva

Phase 1

An Open-Label, Dose Escalation, Multi-Center Phase I/II Clinical Trial of ECT204 T-Cell Therapy in Adults With Advanced Hepatocellular Carcinoma (HCC)

This is an open-label, multi-center, Phase 1/2 clinical trial evaluating the safety, tolerability, and efficacy of ECT204, an investigational ARTEMIS® T-cell t…

Hepatocellular CarcinomaLiver Cancer, AdultLiver Neoplasm+1 more

Estimated

~$10 – $8,750

Eureka Therapeutics Inc.NCT04864054

Phase 2

Utilizing Parenchymal Blood Volume Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial Nitroglycerin

This is a single-arm, open-label, single-center, first-in-human feasibility study evaluating parenchymal blood volume (PBV) imaging as a tool to dynamically as…

Hepatocellular Carcinoma (HCC)Liver Cancer, Adult

Estimated

~$10 – $5,625

University of California, San FranciscoNCT07682454

ObservationalRemote eligible

Feasibility Study of Time Restricted Eating and a Healthy Diet in Patients Receiving Liver-Directed Therapy for Hepatocellular Carcinoma

This is a feasibility study that will collect data to assess the potential effect of nutritional intervention. This prospective single-site trial will enroll a…

Liver Cancer, AdultMASH - Metabolic Dysfunction-Associated SteatohepatitisObesity and Overweight

Estimated

~$10 – $6,250

University of California, San DiegoNCT06824974

Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients With Abdominal and Pelvic Tumors Undergoing Therapy

This clinical trial studies how well 3-dimensional multi-parametric ultrasound (3D MPUS) imaging works as a decision-support tool for patients with liver tumor…

Liver Cancer, Adult

Estimated

~$10 – $750

University of California, San DiegoNCT05705219